Literature DB >> 16905604

Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow.

Uzoma M Okorie1, Scott L Diamond.   

Abstract

Microarraying allows the spatial and compositional control of surfaces, typically for the purpose of binding reactions. Collagen and/or von Willebrand Factor (vWF) in 5% glycerol was contact printed onto glass slides to create defined microspots (176-microm diameter) of adsorbed protein without sample dehydration. The arrays were mounted on flow chambers allowing video microscopy during perfusion (wall shear rate of 100-500 s(-1)) of recalcified corn trypsin inhibitor-treated whole blood or platelet rich plasma and subsequent array scanning via anti-GPIbalpha and anti-fibrin(ogen) immunofluorescence. To mimic the subendothelial matrix, vWF was microarrayed over sonicated type I collagen microspots. For whole blood perfusion (500 s(-1), 10 min) over collagen, vWF, and collagen/vWF microspots, the amount of platelet deposition on the collagen/vWF spots was approximately 2 times greater in comparison to the collagen spots and approximately 18 times greater in comparison to the vWF spots. The amount of fibrin(ogen) deposition on the collagen/vWF spots was approximately 2 times greater in comparison to the collagen spots and approximately 4 times greater in comparison to the vWF spots. This protocol allowed for highly uniform (CV = 18%) and precisely located thrombus formation at a density of >or=400 spots/cm(2). Microarrays are ideal for the combinatorial assembly of adhesive and procoagulant proteins to study thrombosis as well as to study axial and lateral transport effects between discrete microspots of distinct composition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905604      PMCID: PMC1614503          DOI: 10.1529/biophysj.106.083287

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  36 in total

1.  High-fidelity mRNA amplification for gene profiling.

Authors:  E Wang; L D Miller; G A Ohnmacht; E T Liu; F M Marincola
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

2.  Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms.

Authors:  M S Goel; S L Diamond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

3.  Neutrophil-bead collision assay: pharmacologically induced changes in membrane mechanics regulate the PSGL-1/P-selectin adhesion lifetime.

Authors:  K E Edmondson; W S Denney; S L Diamond
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

4.  Functional self-association of von Willebrand factor during platelet adhesion under flow.

Authors:  Brian Savage; Jan J Sixma; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

5.  Proteomic profiling of the cancer microenvironment by antibody arrays.

Authors:  V Knezevic; C Leethanakul; V E Bichsel; J M Worth; V V Prabhu; J S Gutkind; L A Liotta; P J Munson; E F Petricoin; D B Krizman
Journal:  Proteomics       Date:  2001-10       Impact factor: 3.984

6.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

7.  Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.

Authors:  P André; C V Denis; J Ware; S Saffaripour; R O Hynes; Z M Ruggeri; D D Wagner
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

8.  Microarrays of cells expressing defined cDNAs.

Authors:  J Ziauddin; D M Sabatini
Journal:  Nature       Date:  2001-05-03       Impact factor: 49.962

9.  Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.

Authors:  A S Ribba; I Loisel; J M Lavergne; I Juhan-Vague; B Obert; G Cherel; D Meyer; J P Girma
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

Review 10.  Engineering design of optimal strategies for blood clot dissolution.

Authors:  S L Diamond
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

View more
  15 in total

1.  Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow.

Authors:  Uzoma M Okorie; William S Denney; Manash S Chatterjee; Keith B Neeves; Scott L Diamond
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

2.  P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.

Authors:  S F Maloney; Lawrence F Brass; S L Diamond
Journal:  Integr Biol (Camb)       Date:  2010-01-05       Impact factor: 2.192

3.  A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood.

Authors:  Keith B Neeves; Scott L Diamond
Journal:  Lab Chip       Date:  2008-04-03       Impact factor: 6.799

4.  The role of fibrinogen spacing and patch size on platelet adhesion under flow.

Authors:  Aurore B Van de Walle; Jeffrey Fontenot; Travis G Spain; Daniel B Brunski; Ernest S Sanchez; Joel C Keay; Mark E Curtis; Matthew B Johnson; Trevor A Snyder; David W Schmidtke
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

5.  High content evaluation of shear dependent platelet function in a microfluidic flow assay.

Authors:  Ryan R Hansen; Adam R Wufsus; Steven T Barton; Abimbola A Onasoga; Rebecca M Johnson-Paben; Keith B Neeves
Journal:  Ann Biomed Eng       Date:  2012-09-22       Impact factor: 3.934

Review 6.  Systems Analysis of Thrombus Formation.

Authors:  Scott L Diamond
Journal:  Circ Res       Date:  2016-04-29       Impact factor: 17.367

Review 7.  In microfluidico: Recreating in vivo hemodynamics using miniaturized devices.

Authors:  Shu Zhu; Bradley A Herbig; Ruizhi Li; Thomas V Colace; Ryan W Muthard; Keith B Neeves; Scott L Diamond
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

Review 8.  Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.

Authors:  Brian R Branchford; Christopher J Ng; Keith B Neeves; Jorge Di Paola
Journal:  Thromb Res       Date:  2015-05-21       Impact factor: 3.944

Review 9.  The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury.

Authors:  Keith B Neeves; Abimbola A Onasoga; Adam R Wufsus
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

10.  Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays.

Authors:  Keith B Neeves; Abimbola A Onasoga; Ryan R Hansen; Jessica J Lilly; Diana Venckunaite; Meghan B Sumner; Andrew T Irish; Gary Brodsky; Marilyn J Manco-Johnson; Jorge A Di Paola
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.